Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial
Topical 3% minoxidil represents an effective, safe, and well-tolerated adjunctive treatment for facial hair enhancement in transgender men receiving GAHT.
Authors
- Yanisa Ratanapokasatit (ORCID: https://orcid.org/0000-0001-8303-3323)
- Kantarat Wattanawinitchai
- Cherrin Pomsoong (ORCID: https://orcid.org/0000-0001-5511-1937)
- Poonkiat Suchonwanit
Institutions
- Ramathibodi Hospital (TH)
- Srinakharinwirot University (TH)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1080/09546634.2026.2638637
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00